Sorry, but nothing matched your search terms. Please try again with some different keywords.
Nothing Found
- Thousands of children got tested for lead with faulty devices: What parents should know
- Skye Bioscience ends eye disease R&D efforts after glaucoma drug’s phase 2 fail
- Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
- Oculis sees promise in dry eye disease subgroup, plans phase 3
- NIAID is ‘on the ball’ with H5N1 research, but gaps in bird flu prevention remain: experts
- Abbott claims FDA clearances for pair of over-the-counter diabetes trackers
- Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
- NIH blends primary care with clinical research in $30M pilot to reach underserved patients
- Weekly Applications for US Jobless Benefits Fall to the Lowest Level in 4 Months
- Wall Street Soars to Records as Dow Leaps 500 in a Rate-Cut Rally That Swept the World